Publications by authors named "Ueno N"

Article Synopsis
  • - Familial adenomatous polyposis (FAP) is an inherited condition linked to mutations in the APC gene, leading to many colorectal polyps and a high risk of colorectal cancer, usually diagnosed through colonoscopy.
  • - Recent advancements like whole-genome array comparative genomic hybridization (a-CGH) have improved the detection of genetic imbalances associated with FAP, allowing for more precise patient assessment.
  • - In a study focusing on patients with complete APC gene deletions, researchers found varied genetic loss sizes and identified EPB41L4A as a candidate gene that may be linked to neurodevelopmental issues in some patients.
View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Among TNBC subtypes, the luminal androgen receptor (LAR) subtype expresses high levels of androgen receptor (AR) and generally responds poorly to neoadjuvant chemotherapy. AR has been reported as a promising therapeutic target for the LAR TNBC subtype.

View Article and Find Full Text PDF

Background: The involvement of Mediterranean fever (MEFV) gene mutations in patients with inflammatory bowel disease unclassified (IBDU) remains unclear. This study aimed to determine the clinical characteristics and responsiveness to colchicine in Japanese patients with IBDU carrying MEFV mutations.

Methods: In this retrospective cohort study, we examined MEFV mutations using gene analysis, clinical information, and colchicine responsiveness.

View Article and Find Full Text PDF
Article Synopsis
  • Triple-negative inflammatory breast cancer (TN-IBC) is the most aggressive form of breast cancer, and its specific genetic and immune characteristics are not well understood.
  • This study conducted extensive genomic analyses of TN-IBC tumors from a phase II clinical trial, comparing them to stage III triple-negative non-inflammatory breast cancer (TN-non-IBC) samples.
  • Key findings revealed that TN-IBC tumors have unique features, such as a lower mutation load and the presence of immune components that may hinder chemotherapy response, indicating a need for further research to identify potential biomarkers and treatment targets.
View Article and Find Full Text PDF

Several studies reported various crossmodal correspondences related to tactile features. These previous studies have investigated tactile-related correspondences through explicit matching or subjective evaluation tasks, which required participants to recognize relationships between tactile and other sensory features or rate tactile materials on scales with adjective labels related to visual or auditory features. However, these tasks are prone to occur the experimenter-expectancy effects and arbitrary categorization of tactile materials by the labels, making it difficult to assess implicit and non-arbitrary aspects of crossmodal correspondences.

View Article and Find Full Text PDF
Article Synopsis
  • * A study involving 42 patients from various international centers aimed to measure the effectiveness of combining ICIs with chemotherapy, with expectations of improved 6-month progression-free survival (rwPFS) rates.
  • * Results revealed a disappointing 6-month rwPFS rate of 30% and a median overall survival of 15.7 months for patients, prompting a call for further research on the efficacy of immunotherapy in mTN-IBC, contrary to earlier expectations regarding its immune-vulnerability.
View Article and Find Full Text PDF

Background: Neoadjuvant chemotherapy (NACT) became a standard treatment strategy for patients with inflammatory breast cancer (IBC) because of high disease aggressiveness. However, given the heterogeneity of IBC, no molecular feature reliably predicts the response to chemotherapy. Whole-exome sequencing (WES) of clinical tumor samples provides an opportunity to identify genomic alterations associated with chemosensitivity.

View Article and Find Full Text PDF

Background: Differences in the incidence of breast cancer subtypes among racial/ethnic groups have been evaluated as a contributing factor in disparities seen in breast cancer prognosis. We evaluated new breast cancer cases in Hawai'i to determine if there were subtype differences according to race/ethnicity that may contribute to known disparities.

Methods: We reviewed 4591 cases of women diagnosed with breast cancer from two large tumor registries between 2015 and 2022.

View Article and Find Full Text PDF

Cancer-associated macrophage-like cells (CAMLs) are rare, gigantic, and atypical circulating cells found exclusively in the peripheral blood of patients with solid cancers. Obesity-induced hypoxia attracts macrophages to the tumor microenvironment, where they contribute to establishing chronic inflammation, leading to cancer progression. We hypothesized that obese patients with advanced breast cancer may have CAML profiles different from those of nonobese patients, and these profiles may correlate with proinflammatory markers or other macrophage-related markers.

View Article and Find Full Text PDF

We herein present the case of a 30-year-old Japanese male patient with ulcerative colitis (UC) who was admitted to our hospital because of significant ascites. Upon evaluation, the patient was diagnosed with unresectable UC-associated cancer (UCAC), localized in the transverse colon. Using gene profiling of the tumor tissue, anti-epidermal growth factor receptor (EGFR) antibody combination chemotherapy was selected.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of the anti-EGFR monoclonal antibody panitumumab combined with carboplatin and paclitaxel for treating chemotherapy-resistant triple-negative breast cancer (TNBC) patients.
  • It included 43 patients who had not sufficiently responded to prior doxorubicin and cyclophosphamide treatment, achieving a combined pathological complete response/residual cancer burden class I rate of 30.2%.
  • The results indicate that panitumumab shows promise as part of neoadjuvant therapy for TNBC, warranting further evaluation in larger clinical trials.
View Article and Find Full Text PDF

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, accounting for 30% of non-Hodgkin lymphomas. Although comprehensive analysis of genetic abnormalities has led to the classification of lymphomas, the exact mechanism of lymphomagenesis remains elusive. The Ets family transcription factor, PU.

View Article and Find Full Text PDF

Solid tumours induce systemic immunosuppression that involves myeloid and T cells. B cell-related mechanisms remain relatively understudied. Here we discover two distinct patterns of tumour-induced B cell abnormality (TiBA; TiBA-1 and TiBA-2), both associated with abnormal myelopoiesis in the bone marrow.

View Article and Find Full Text PDF

Genetically engineered CD8 T cells are being explored for the treatment of various cancers. Analytical characterization represents a major challenge in the development of genetically engineered cell therapies, especially assessing the potential off-target editing and product heterogeneity. As conventional sequencing techniques only provide information at the bulk level, they are unable to detect off-target CRISPR translocation or editing events occurring in minor cell subpopulations.

View Article and Find Full Text PDF

Purpose: In preclinical models, glucocorticoid receptor (GR) signaling drives resistance to taxane chemotherapy in multiple solid tumors via upregulation of antiapoptotic pathways. ORIC-101 is a potent and selective GR antagonist that was investigated in combination with taxane chemotherapy as an anticancer regimen preclinically and in a phase 1 clinical trial.

Patients And Methods: The ability of ORIC-101 to reverse taxane resistance was assessed in cell lines and xenograft models, and a phase 1 study (NCT03928314) was conducted in patients with advanced solid tumors to determine the dose, safety, and antitumor activity of ORIC-101 with nab-paclitaxel.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-HER2 therapies like trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) have improved outcomes for patients with HER2+ metastatic breast cancer, but resistance to these treatments poses a significant challenge without established follow-up therapies.
  • The study examined genetic changes in breast cancer patients after anti-HER2 therapy and developed resistant cancer cell lines to explore mechanisms of resistance and identify potential targets to boost the effectiveness of T-DXd.
  • It was discovered that resistance might occur due to reduced HER2 expression and increased activity of DNA repair genes, suggesting that targeting DNA repair pathways could enhance the efficacy of T-DXd in resistant cases.
View Article and Find Full Text PDF

Introduction: Unsedated peroral endoscopy, including ultrathin endoscopy (UE) and conventional endoscopy (CE), is feasible in clinical practice but requires improved endoscopic operability and patient tolerance. Currently, the impact of the breathing method on these factors remains unclear. We conducted the first randomized controlled trial comparing oral breathing (OB) and nasal breathing (NB) during both UE and CE to assess their influence.

View Article and Find Full Text PDF

Therapeutic resistance presents a significant hurdle in combating inflammatory breast cancer (IBC), adding to the complexity of its management. To investigate these mechanisms, we conducted a comprehensive analysis using transcriptomic and proteomic profiling in a preclinical model alone with correlates of treatment response in IBC patients. This included SUM149 cell lines derived from treatment-naïve patients, along with acquired drug resistance (rSUM149) and others in a state of resistance reversal (rrSUM149), aiming to uncover drug resistance networks.

View Article and Find Full Text PDF

During the formation of the neural tube, the primordium of the vertebrate central nervous system, the actomyosin activity of cells in different regions drives neural plate bending. However, how the stiffness of the neural plate and surrounding tissues is regulated and mechanically influences neural plate bending has not been elucidated. Here, we used atomic force microscopy to reveal the relationship between the stiffness of the neural plate and the mesoderm during Xenopus neural tube formation.

View Article and Find Full Text PDF

Background: Despite lower chemotherapy use in older triple-negative breast cancer (TNBC) patients, their outcomes match younger counterparts. We compared outcomes in early-stage TNBC patients by age receiving chemotherapy at a major cancer center with a national TNBC database.

Methods: Retrospective study using institutional data on stage I-III TNBC (ER/PR < 10%) women with neoadjuvant/adjuvant chemotherapy.

View Article and Find Full Text PDF

Gastric adenocarcinoma of the fundic gland type (GA-FG) is characterized by an elevated lesion with vessel dilation exhibiting branching architecture (DVBA). However, this feature is also found in fundic gland polyps (FGPs), posing a challenge in their differentiation. In this study, we aimed to investigate the clinicopathological features of gastric elevated lesions with DVBA and assess the efficacy of the white ring sign (WRS) as a novel marker for distinguishing between FGPs and GA-FGs.

View Article and Find Full Text PDF

Luminal androgen receptor (LAR)-enriched triple-negative breast cancer (TNBC) is a distinct subtype. The efficacy of AR inhibitors and the relevant biomarkers in neoadjuvant therapy (NAT) are yet to be determined. We tested the combination of the AR inhibitor enzalutamide (120 mg daily by mouth) and paclitaxel (80 mg/m weekly intravenously) (ZT) for 12 weeks as NAT for LAR-enriched TNBC.

View Article and Find Full Text PDF

Organic electrolytes with Li were analyzed by far-ultraviolet (≤200 nm) spectroscopy, achieved by an attenuated total reflectance setup. The spectra showed a redshift with Li addition, attributed to the charge transfer, as revealed by quantum chemical calculations. Multivariate analysis successfully decomposed the spectra into pure solvent and Li-coordinated solvent components.

View Article and Find Full Text PDF

Introduction: Carbazochrome sodium sulfonate (CSS) is a hemostatic agent that reduces capillary permeability and enhances capillary resistance. However, its specific effects on colorectal endoscopic submucosal dissection (ESD) outcomes remain uncertain. This study aimed to assess the risk factors for post-ESD bleeding and the effect of CSS on colorectal ESD outcomes.

View Article and Find Full Text PDF